Please login to the form below

Not currently logged in
Email:
Password:

Aptiv

This page shows the latest Aptiv news and features for those working in and with pharma, biotech and healthcare.

Icon boost medical device trial capability with Aptiv acquisition

Icon boost medical device trial capability with Aptiv acquisition. Deal will also enhance the CRO's position inadaptive trials and in Japan. ... Dublin-based contract research organisation Icon has acquired Aptiv Solutions for $143.5m, boosts its

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    Aptiv Solutions/ ICON. Acquisition. CRO/ Adaptive Clinical Trials. 143.5. California Stem Cell/ NeoStem.

  • Pharma deals during April 2014 Pharma deals during April 2014

    Mallinckrodt, Ranbaxy Laboratories/ Sun Pharmaceuticals; Silom Medical Company/ Actavis), Pharmaceuticals/Biologics (Furiex/ Forest Laboratories, Andromeda Biotech/ Hyperion Therapeutics), OTC (Insight Pharmaceuticals/ Prestige Brands), Diagnostics

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics